Bruker BioSpin Corp.
15 Fortune Drive Manning Park Billerica, MA, 01821-3991 Website: http://www.bruker-biospin.com




|
 |

Nuclear Magnetic Resonance In Structural Proteomics
by Clemens Anklin, Ph.D.
Figure 1: The Bruker BioSpin Avance 900 MHz NMR System.
|
After nearly four decades of advancements in both technology and methodology,
Nuclear Magnetic Resonance (NMR) spectroscopy now plays an important role in
a wide range of research fields, including structural proteomics. This progress
results from tight collaboration between manufacturers and the researchers who
develop methods.
Initially, the use of NMR was limited to physics. Improvements in sensitivity
and resolution made it a useful method for chemists. The introduction of Fourier
transform (FT) NMR and, about a decade later, two- dimensional FT-NMR, allowed
the study of larger, more complex compounds. In the 1970s, the first attempts
to study biomolecules by NMR resulted in useful structural information, facilitating
its use as a tool for biochemists and molecular biologists. Methods development
over the last 20 years, together with the availability of higher magnetic fields,
has expanded the application of NMR to its current role in structural proteomics.
The study of proteins with molecular weights over 100 kDa is made a reality.
For all molecules that readily form single crystals, x-ray crystallography will
always be the method of choice, and cryo Electron Microscopy provides spectacular
data of very large assemblies. NMR, on the other hand, is uniquely suited to
deliver structural information on molecules that are difficult to crystallize.
NMR is also preferred for obtaining information about the dynamics of biological
molecules.
Obtaining structural information
Structural information from NMR spectra can be mainly obtained from two observables
— spin coupling and the nuclear Overhauser effect. Spin coupling acts
through chemical bonds and primarily provides information about connectivity
within molecules. A large variety of experiments have been developed to establish
correlations between atoms that exhibit coupling. These will eventually allow
assignment of every signal in a spectrum to a specific atom in the molecule.
Because the magnitude of the coupling is affected by bond angles, information
about relative orientation of bonds can be obtained and used for the calculation
of structures. The nuclear Overhauser effect acts through space. Its magnitude
is proportional to the distance between two atoms. With the assignment information
obtained with these two methods, the spatial proximity of two atoms can be established
and constraints for structural calculations can be obtained.
Figure 2: Bruker BioSpin Avance ICE 600 MHz — Integrated CryoProbe NMR
System.
|
Leaders in the application of NMR
Much of the seminal work on the determination of protein structures by NMR was
done in the laboratory of Dr. Kurt Wuethrich at the Swiss Federal Institute
of Technology (ETH) in Zurich, Switzerland. This work was honored when Professor
Wuethrich was awarded the 2002 Nobel Prize in Chemistry. In the early 1980s,
one of the essential technological factors for the success of this work was
the introduction of magnets with a field strength of 11.7 T corresponding to
a proton resonance frequency of 500 MHz. To build such magnets, the processing
of a new superconducting alloy, NbSn3, had to be mastered. This alloy is so
brittle that it cannot be wound into coils. The only viable solution is to use
a wire made of Niobium filaments in a Cu/Sn bronze matrix, wind it into a coil,
and then to treat this material over long periods at elevated temperatures.
The development of experimental techniques using two-dimensional NMR, together
with the higher fields, allowed protein structures with molecular weights as
high as 10 — 15 kDa to be determined in the 1980s. The major factor preventing
the study of larger molecules was increasing spectral complexity. Later in that
decade, the use of proteins uniformly labeled with the NMR active nuclei, carbon-13
and nitrogen-15, enabled the introduction of triple resonance experiments, pioneered
by NIH researcher Ad Bax and his coworkers on a Bruker AM600 MHz spectrometer.
These experiments used the separation of the resonance signals along multiple
chemical shift dimensions to resolve signals that are overlapped when only observing
hydrogen. They also allow the collection of sequential information along the
polypeptide chain by unambiguously correlating hydrogens, carbons and nitrogens,
both with one amino acid and across the peptide bond.
Figure 3: Magnetic Shielding Diagram compares NMR Magnets without shielding,
and with Bruker Biospin UltraShield and UltraShield Plus shielding.
|
Higher field strengths, higher sensitivity
The next major breakthrough in NMR technology came in the early 1990s when the
next generation of NMR magnets was introduced — first the 750 MHz and
later the 800 MHz systems. Higher magnetic fields increase the dispersion of
the signals and lead to higher sensitivity. These two factors again allow the
study of larger proteins. With these systems, NMR can easily study proteins
up to 20 — 25 kDa. One of the challenges of ultra high field magnets is
the need for an extremely stable system that displays no fluctuations in the
magnetic field strength. Bruker BioSpin Corporation achieved this by implementing
a unique system in which a small cooling device, based on the Joule-Thomson
effect, cools the entire coil to a temperature near 2 Kelvin. With this design,
the helium vessel itself stays at regular atmospheric pressure and can be operated
like traditional lower field magnets. In 2001, this technology allowed the first
customer installation of a Bruker BioSpin Avance 900 MHz spectrometer, at The
Scripps Research Institute in La Jolla, California. Research is underway in
several laboratories and companies to reach the next level of magnetic fields.
Advances in shielding technology
Active magnet shielding technology, which reduces the stray fields around the
superconducting magnet systems, has also played an important role in advancing
the application of NMR. Reducing the stray field allows easier system siting
and permits the use of equipment such as HPLCs, mass spectrometers and liquid
handling instruments that would otherwise be affected by the magnet. Actively
shielded magnets are currently available up to 800 MHz. The shielded high-field
magnets exhibit a smaller stray field than a traditional 500 MHz magnet.
Cryogenics for a quantum leap in sensitivity
After years of incremental increases in sensitivity, the introduction of cryogenically
cooled probes represented a quantum leap for NMR spectroscopy. These probes,
with cold Rf coils and preamplfiers, increased sensitivity by a factor of four
or more. The resulting increase in throughput and lower detection limits allows
entirely new approaches to NMR. In the case of structural proteomics this means
that data on a sample can be collected in less than one-tenth of the time or
that a concentration one order of magnitude lower can be used. This addresses
two of the major shortcomings of NMR spectroscopy that had persisted up to this
point. In the past, it could take as long as several weeks to collect the data
required for assignment and structural calculation of a protein. With a CryoProbe
(Bruker BioSpin), this can be reduced in the best case to less than 24 hours.
Using automated analysis routines, Dr. Gaetano Montelione of Rutgers University
has shown that an actual protein structure can be obtained in less than one
day. Working with lower concentration eliminates time-consuming optimization
of solution conditions and often prevents the protein from forming aggregates.
The benefits of the CryoProbes were recognized early on by Dr. Steve Fesik from
Abbott Laboratories. The higher sensitivity allowed him to increase the throughput
for his SAR by NMR method by a factor of ten.
Figure 4: What NMR systems used to look like, HX-90 NMR.
|
Studying larger proteins
At this point NMR was still limited to small- to medium-sized proteins for structural
studies. Molecules larger than 30 — 40 kDa display very unfavorable relaxation
behavior, leading to signal losses that make many of the experiments fail. The
introduction of Transverse Relaxation Optimized Spectroscopy (TROSY) in 1999,
by Dr. K. Wuethrich and his coworker, K. Pervushin, broke this barrier and made
the study of much larger proteins possible. Proteins weighing in excess of 100
kDa have now been studied. These advances have also been facilitated by new
methods in sample preparation. Replacement of most hydrogen atoms in a protein
by deuterium, directed partial isotopic labeling, and segmental labeling have
been used to simplify the spectra of very large molecules, further aiding the
analysis of the data from very large proteins.
Conclusion
In the early days of structural proteomics, or structure determination by NMR
as it was referred to then, obtaining a single structure could take over a year.
Today, the same structure can be determined in a matter of days. This has resulted
in NMR changing from a research method used by a few to a vital tool for a large
variety of scientists.
NMR technological developments continue. The push for higher fields continues
and will eventually result in the 1 GHz spectrometer. This will not only give
the scientist a more powerful instrument, but also will, as has been shown in
the past, make lower field instruments more effective because many of the developments
required for the high field instruments can be translated down to the other
spectrometers. Research continues in the improved performance of both cryogenically
cooled and conventional NMR probes. Scaling down measurement volumes will increase
sensitivity and reduce sample requirements. In addition to these developments,
mostly driven by instrument manufacturers, NMR users will develop new applications,
methods and experiments.
About the author
Clemens Anklin, Ph.D., is Vice President, Applications/Training with Bruker
BioSpin Corporation.
More information regarding the use of NMR in structural proteomics is available
from: Bruker BioSpin Corp.
Use InfoLINK 4A1502 or Call 800-287-0633
|